Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer

Completed · Not applicable

Conditions studied: Osteoporosis, Prostate Cancer

In brief

RATIONALE: Assessing the effect of androgen suppression on bone loss in prostate cancer patients may improve the ability to plan treatment, may decrease the risk of fractures and bony pain, and may help patients live more comfortably. PURPOSE: Clinical trial to determine the effect of androgen suppression on bone loss in patients who have prostate cancer.

Key facts

Study ID

NCT00003903

Run by

University of Rochester

People needed

150

Starts

1999-07-01

Expected to finish

2007-08-01

Last updated by the study team

2013-10-16

Who can join

Age: any. Sex: male. Healthy volunteers: not accepted.

Where it is running

• James P. Wilmot Cancer Center — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.